| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |